Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BIRC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CENPV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM216A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTL8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C12orf73 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM72A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DEPDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HBS1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UMPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on